Cargando…

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus

Ethnicity is a key factor impacting on disease severity in SLE, but molecular mechanisms of these associations are unknown. Type I IFN and MIF have each been associated with SLE pathogenesis. We investigated whether increased SLE severity in Asian patients is associated with either MIF or Type I IFN...

Descripción completa

Detalles Bibliográficos
Autores principales: Connelly, K. L., Kandane-Rathnayake, R., Hoi, A., Nikpour, Mandana, Morand, E. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958969/
https://www.ncbi.nlm.nih.gov/pubmed/27453287
http://dx.doi.org/10.1038/srep29909
_version_ 1782444348623814656
author Connelly, K. L.
Kandane-Rathnayake, R.
Hoi, A.
Nikpour, Mandana
Morand, E. F.
author_facet Connelly, K. L.
Kandane-Rathnayake, R.
Hoi, A.
Nikpour, Mandana
Morand, E. F.
author_sort Connelly, K. L.
collection PubMed
description Ethnicity is a key factor impacting on disease severity in SLE, but molecular mechanisms of these associations are unknown. Type I IFN and MIF have each been associated with SLE pathogenesis. We investigated whether increased SLE severity in Asian patients is associated with either MIF or Type I IFN. SLE patients (n = 151) had prospective recording of disease variables. Serum MIF, and a validated composite score of three Type I IFN-inducible chemokines (IFNCK:CCL2, CXCL10, CCL19) were measured. Associations of MIF and IFNCK score with disease activity were assessed, with persistent active disease (PAD) used as a marker of high disease activity over a median 2.6 years follow up. In univariable analysis, MIF, IFNCK score and Asian ethnicity were significantly associated with PAD. Asian ethnicity was associated with higher MIF but not IFNCK score. In multivariable logistic regression analysis, MIF (OR3.62 (95% CI 1.14,11.5), p = 0.03) and Asian ethnicity (OR3.00 (95% CI 1.39,6.46), p < 0.01) but not IFNCK were significantly associated with PAD. These results potentially support an effect of MIF, but not Type I IFN, in heightened SLE disease severity in Asian SLE. The associations of MIF and Asian ethnicity with PAD are at least partly independent.
format Online
Article
Text
id pubmed-4958969
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49589692016-08-04 Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus Connelly, K. L. Kandane-Rathnayake, R. Hoi, A. Nikpour, Mandana Morand, E. F. Sci Rep Article Ethnicity is a key factor impacting on disease severity in SLE, but molecular mechanisms of these associations are unknown. Type I IFN and MIF have each been associated with SLE pathogenesis. We investigated whether increased SLE severity in Asian patients is associated with either MIF or Type I IFN. SLE patients (n = 151) had prospective recording of disease variables. Serum MIF, and a validated composite score of three Type I IFN-inducible chemokines (IFNCK:CCL2, CXCL10, CCL19) were measured. Associations of MIF and IFNCK score with disease activity were assessed, with persistent active disease (PAD) used as a marker of high disease activity over a median 2.6 years follow up. In univariable analysis, MIF, IFNCK score and Asian ethnicity were significantly associated with PAD. Asian ethnicity was associated with higher MIF but not IFNCK score. In multivariable logistic regression analysis, MIF (OR3.62 (95% CI 1.14,11.5), p = 0.03) and Asian ethnicity (OR3.00 (95% CI 1.39,6.46), p < 0.01) but not IFNCK were significantly associated with PAD. These results potentially support an effect of MIF, but not Type I IFN, in heightened SLE disease severity in Asian SLE. The associations of MIF and Asian ethnicity with PAD are at least partly independent. Nature Publishing Group 2016-07-25 /pmc/articles/PMC4958969/ /pubmed/27453287 http://dx.doi.org/10.1038/srep29909 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Connelly, K. L.
Kandane-Rathnayake, R.
Hoi, A.
Nikpour, Mandana
Morand, E. F.
Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
title Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
title_full Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
title_fullStr Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
title_full_unstemmed Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
title_short Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
title_sort association of mif, but not type i interferon-induced chemokines, with increased disease activity in asian patients with systemic lupus erythematosus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958969/
https://www.ncbi.nlm.nih.gov/pubmed/27453287
http://dx.doi.org/10.1038/srep29909
work_keys_str_mv AT connellykl associationofmifbutnottypeiinterferoninducedchemokineswithincreaseddiseaseactivityinasianpatientswithsystemiclupuserythematosus
AT kandanerathnayaker associationofmifbutnottypeiinterferoninducedchemokineswithincreaseddiseaseactivityinasianpatientswithsystemiclupuserythematosus
AT hoia associationofmifbutnottypeiinterferoninducedchemokineswithincreaseddiseaseactivityinasianpatientswithsystemiclupuserythematosus
AT nikpourmandana associationofmifbutnottypeiinterferoninducedchemokineswithincreaseddiseaseactivityinasianpatientswithsystemiclupuserythematosus
AT morandef associationofmifbutnottypeiinterferoninducedchemokineswithincreaseddiseaseactivityinasianpatientswithsystemiclupuserythematosus